Article
LUNAR: A Deep Learning Model to Predict Glioma Recurrence Using Integrated Genomic and Clinical Data
2024-10-24
Abstract excerpt
Gliomas account for approximately 25.5% of all primary brain and central nervous system tumors, with a striking 80.8% of these being malignant. The prognosis varies significantly; low-grade gliomas (LGGs) can exhibit 5-year survival rates of up to 80%, while higher-grade gliomas (HGGs) often see rates below 5%. Recurrence is a common challenge, occurring in 52%-62% of LGGs and 90% of HGGs, complicating clinical ma...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 49f21148-a334-504b-b34c-f9e31685eb4f
- DOI
- 10.1101/2024.10.23.619762
